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Summary 
 
Global dispersal and increasing frequency of the SARS-CoV-2 Spike protein variant D614G are 
suggestive of a selective advantage but may also be due to a random founder effect. We 
investigate the hypothesis for positive selection of Spike D614G in the United Kingdom using 
more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large 
data set, well represented by both Spike 614 variants, not all approaches showed a conclusive 
signal of positive selection. Population genetic analysis indicates that 614G increases in 
frequency relative to 614D in a manner consistent with a selective advantage. We do not find 
any indication that patients infected with the Spike 614G variant have higher COVID-19 
mortality or clinical severity, but 614G is associated with higher viral load and younger age of 
patients. Significant differences in growth and size of 614G phylogenetic clusters indicate a 
need for continued study of this variant. 
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Introduction 
 
SARS-CoV-2, the coronavirus causing the global COVID-19 pandemic, is a rapidly-evolving 
RNA virus that continually accrues genomic mutations as it transmits. A major focus of current 
research into SARS-CoV-2 genetics is whether any of these mutations have the potential to 
significantly alter important viral properties, such as the mode or rate of transmission, or the 
ability to cause disease. Evolutionary theory predicts that most new viral mutations are 
deleterious and short-lived, whereas mutations that persist and grow in observed frequency may 
be either selectively neutral, or advantageous to viral fitness. Discriminating between these two 
scenarios and determining the selective benefit of new mutations is challenging, particularly for 
a newly-emergent virus such as SARS-CoV-2. For example, the observation that a new 
mutation is increasing in prevalence or geographic range is, by itself, insufficient to prove its 
selective advantage to the virus, because such increases can be generated by neutral 
epidemiological processes such as genetic bottlenecks following founder events and range 
expansions.  
 
Considerable attention has focussed on the D614G mutation in SARS-CoV-2, a 
non-synonymous mutation resulting in a change from aspartic acid to glycine at position 614 of 
the virus’ S protein (D614G). The trimeric S protein, composed of subunits S1 and S2, is a large 
glycoprotein that mediates cell entry and has been studied extensively in other coronaviruses, 
including SARS-CoV ​(Belouzard et al., 2009; Li, 2015; Li et al., 2005)​ and MERS ​(Millet and 
Whittaker, 2014; Yang et al., 2014)​. SARS-CoV-2 S protein binds to angiotensin-converting 
enzyme 2 (ACE2) to gain cell entry, hence mutations in this gene have the potential to alter 
receptor binding affinity and infectivity, as well as viral immune evasion and 
immunogenicity​(Watanabe et al., 2020)​. 
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Figure 1 | ​Maximum likelihood phylogeny estimated from a representative set of 900 
SARS-CoV-2 genome sequences, showing global lineage assignments and the origins of 
the Spike protein D614G mutation which seeded many introductions in the United Kingdom. 
Putative reversions to 614D and independently arising D614G mutations are shown as large 
circles. The D614N genomes shown as red circles indicated two independent clusters in the 
UK.  
 
 
The putative importance of the D614G mutation is based on three distinct sets of observations. 
First, experimental work using pseudotyped lentiviruses indicate that D614G increases 
infectivity ​in vitro​ ​(Korber et al., 2020; Yurkovetskiy et al.; Zhang et al., 2020)​. Second, structural 
analysis suggests that D614G alters the receptor binding conformation, such that ACE2 binding 
and fusion is more likely ​(Yurkovetskiy et al.)​. Third, analysis of the frequency of the 614D and 
614G variants over time (based on submissions to global sequence databases) have suggested 
that locations which reported 614D viruses early in the pandemic were often later dominated by 
614G viruses ​(Furuyama et al., 2020; Korber et al., 2020)​.  
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The D614G mutation is associated with the B.1 lineage of SARS-CoV-2  (Figure 1), which now 
dominates the global pandemic, based upon global SARS-CoV-2 genome sequences shared 
via GISAID (​https://cov-lineages.org/lineages/lineage_B.1.html ​). Retrospectively-sampled 
viruses suggest this mutation was present in Guangzhou, Sichuan and Shanghai Provinces, 
China in late January (Figure S1). In Europe, the 614G variant was first observed in genomes 
sampled on January 28th in a small outbreak in Bavaria, Germany, which was initiated by a 
visitor from Shanghai ​(Rothe et al., 2020)​ and subsequently controlled through public-health 
efforts. It is therefore likely that the D614G mutation occurred in China before being introduced 
on multiple occasions to European countries ​(Lai et al.)​ where it increased in frequency. This 
scenario is consistent with the rapid increase in February and March of European virus 
genomes that carry the 614G variant ​(Dearlove et al., 2020; Korber et al., 2020)​. In the UK, the 
first observation of a genome carrying the D614G mutation was in a sample collected on 
February 28th from a patient in Scotland who had recently travelled through Italy ​(Robertson, 
2020)​.  
 
There is currently no scientific consensus on the effect of the D614G mutation on SARS-CoV-2 
infectivity and transmissibility, and some skepticism that it could produce a meaningful effect at 
the population level given that SARS-CoV-2 is already highly transmissible and rapidly 
spreading ​(van Dorp et al., 2020; Grubaugh et al., 2020)​. Although evaluating the effect of the 
D614G mutation on infectivity ​in vitro​ using pseudotype viruses is a critical first step, it is more 
challenging to determine whether any identified effects hold true for complete SARS-CoV-2 
variants ​in vitro​ which requires an animal model that accurately reproduces meaningful aspects 
of virus infection and transmission. Even then, animal models may not accurately recapitulate 
the effect of variants on virus transmissibility within the human population. Therefore 
experimental evidence should be complemented with large-scale population studies that can 
detect meaningful changes in human-to-human transmission. The small size of the 
SARS-CoV-2 genomic datasets from many countries precludes robust analysis on a national 
scale. The substantially larger global SARS-CoV-2 sequence dataset is also problematic 
because of limited sequence metadata and variable sampling approaches among countries. To 
determine statistically if there is a meaningful difference in transmission between the 614D and 
614G variants, we ideally need to observe repeated independent introductions of each variant 
into the same population and follow the trajectories of the outbreaks they cause. 
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Figure 2 ​ | Geographic and temporal distribution of UK phylogenetic clusters, classified as 
614D or 614G according to the residue they carry at S protein position 614D.  A) Shaded 
regions show the predominant residue in each region on the 15th of each month for March, 
April, May and June 2020, with orange indicating that 614G was more frequently sampled 
and green indicating that 614D was more (or equally) frequent. Light grey indicates that no 
sequences had been sampled by that point in time. Dark grey indicates the Republic of 
Ireland.  B) The date when each cluster was first detected in the United Kingdom, for 
variants 614D and 614G. Each cluster contains 2 or more sampled genomes. Solid lines 
show the total number of sequences collected by day of each 614 variant. C) The log odds 
of sampling a 614G variant over time. D) The size of cluster versus time of first sample 
collected within a cluster.  
 
In the UK, the rapid establishment of a national sequencing collaboration at the start of the 
epidemic in the UK, CoG-UK ​(The COVID-19 Genomics UK (COG-UK) consortium, 2020)​, has 
resulted in the generation of >40,000 SARS-CoV-2 sequences from the country in <6 months 
(approximately half of all genomes sequenced globally as of the 7th of July). CoG-UK has 
facilitated the usage of robust and systematic sampling, shared bioinformatic and laboratory 
approaches, and the collection of consistent core metadata, resulting in a large, high-resolution 
dataset capable of examining changes in virus biology in the UK. Crucially for this study, and in 
contrast to epidemics that followed the first European outbreaks, the UK epidemic is the result 
of repeated introduction of SARS-CoV-2 from numerous global locations, including a substantial 
number of phylogenetic sub-trees (clusters) carrying either 614D and 614G. Here we use the 
CoG-UK dataset to examine evidence for increased transmissibility of SARS-CoV-2 due to 
genetic changes in its Spike protein. We also investigate the influence of Spike 614D versus G 
on pathogenicity by matching sequence data with clinical outcome. 
 
Results 
 
We identified 21,231 614G and 5,755 614D de-duplicated whole genome sequences sampled 
from different infections within the UK with known dates of sample collection between January 
29 and June 16, 2020. We identified phylogenetic clusters of United Kingdom genomes using a 
maximum-parsimony reconstruction of the location of phylogenetic branches within the global 
SARS-CoV-2 phylogeny (see Methods). Each cluster stems from one or a small number of 
introductions of the virus into the UK. We identify 245 614G and 62 614D clusters containing UK 
virus genomes from 10 or more different patients, after removing samples with Spike 614 
genotype which does not match the majority within their cluster (reversions or contaminations). 
Importantly, we identified more UK phylogenetic clusters carrying the 614G variant than the 
614D variant, and on average the 614G clusters were first detected later (the mean detection 
date for 614G clusters was 16 days later than of 614D clusters; Figure 2). Whilst the frequency 
of sampling of 614G and 614D variants in the UK was close to parity in February and March, 
614G became the dominant form in late March and this trend has continued (Figure 2C).  
 
Evaluating the hypothesis that 614G confers increased transmission fitness. 
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UK phylogenetic clusters that were first detected early in the epidemic tend to be larger than 
those detected later (Figure 2D). Although most 614G clusters tended to be detected later, they 
are on average 59% larger than 614D clusters after adjusting for the time of cluster detection 
(​p​=0.008).  
 
To evaluate if the increasing sampling frequency of 614G reflects a selective advantage, we fit a 
logistic growth model to observed sequence sampling dates, under the assumption that 
sequences are sampled in proportion to the relative frequency of the 614G variants in the 
population, which changes over time.  Under this model, 614D-infected cases grow 
exponentially at a rate  and 614G-infected cases grow exponentially at rate , where  
represents the estimated mutational selection coefficient.   
 
In order to account for the rapid increase in SARS-CoV-2 introduction into the UK during March 
(Pybus et al., 2020)​ we adapted the logistic growth model to count only those sequences that 
belong to clusters first detected in January or February. We further limit the analysis to 
sequences sampled during a period of exponential growth up to the end of March shortly after a 
national lockdown ​ ​was implemented in the UK. Origin times for clusters were estimated using 
molecular clock phylogenetic methods (c.f. Methods). We also only consider samples collected 
after the most recent common ancestor (TMRCA) of the individual TMRCA of all clusters​ ​and 
where there are at least 10 samples with ​either ​amino acids 614D or G. Under these conditions, 
all samples included in the analysis were collected during a period when the selected clusters 
were co-circulating within the UK. 
 
Consequently, for this analysis, we retained 5 614D clusters (n=355 sequences) and 5 614G 
clusters (n=1,855 sequences) and estimated a selection coefficient for the 614G of 0.21 (95% 
CI: 0.06 - 0.56) (Table 1). The observed and fitted frequencies of 614G samples are shown in 
Figures 3A and S2. Information used to fit this model is drawn disproportionately from late 
March when more sequences are available.  
 
We separately fitted the logistic growth model to the period of epidemic decline after April 15. If 
we include all clusters first detected before March 31, then we have n=3,335 sequences (3,093 
614G and 242 614D) sampled after April 15 and belonging to 37 phylogenetic clusters. This 
cross-section of data also exhibits a trend of an increasing frequency of 614G through time 
(Figures 3B and S3), with an estimated selection coefficient of 0.27 (95% CI:0.12-0.54).  
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Table 1 ​| Estimates of the selection coefficient of the 614G variant using different data sets and 
models.  
 
Method 
Selection coefficient 
Logistic growth phase 0.21 (0.06, 0.56)​1 
Logistic decline phase 0.27 (0.12-0.54)​1 
‘Boom-bust’ coalescent model 0.29 (-0.24, 1.18)​2 
Skygrowth coalescent  0.17 (-0.24, 0.57)​2 
London SEIR structured coalescent 0.10 (-0.15, 0.41)​2 
London SEIR with sample frequency data 
 
0.26  (-0.01, 0.58 )​2 
1​maximum likelihood estimate (95% confidence interval) 
2​median posterior (95% credible interval) 
 
 
 
An alternative source of information about the relative growth rates of the two variants comes 
from changing patterns of genetic diversity over time in each cluster. We applied phylodynamic 
methods​(Pybus and Rambaut, 2009)​ to estimate effective population size and effective growth 
rates over time. First, we applied a parametric ‘boom-bust’ exponential growth coalescent model 
to all clusters containing >40 samples, giving 50 clusters (11 for the 614D variant and 39 for 
614G).  
 
Under this model, population size grows exponentially up to a transition time, whereupon it 
shrinks exponentially. Rates of growth and decline and the transition time can vary for each 
614G and 614D cluster but a joint estimate for these are obtained using a hierarchical model 
(see methods). Among the 50 clusters, the 614G clusters tended to start later and persist longer 
than 614D (Figure S4), whilst 614D clusters tended to have slightly earlier transition times 
(614D mean = 25th March, 614G mean = 1st April). We do not detect any significant evidence 
for positive selection of the 614G variant using this model (Table 1), as uncertainty in estimated 
cluster growth rates was large (Figures 3 and S5).  Growth rates for 614G clusters tended to be 
larger (posterior mean = 114 year​-1​, versus 93 year​-1​) as too were the decline rates of 614G 
clusters (posterior mean = -11 year​-1​, versus -9 year​-1​) but these differences were 
non-significant. 
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Further, we applied a non-parametric phylodynamic model that allows virus population size 
growth rate to vary over time according to a stochastic process. We applied this model 
independently to each of the clusters described above. We found that effective population size 
in the largest clusters tracks the progression of the epidemic in the UK and growth in most 
clusters is negative by early April 2020 (Figure S6 A-D). We then examined if the 614G variant 
explained variance in growth rates among phylogenetic clusters. The initial growth rate of each 
cluster was highly variable (Figure S6) and precision of the estimated rate was generally low. 
The Spike protein 614 polymorphism on its own explains very little variance in growth rates 
among clusters (weighted least squares R​2​=1%) and there was no significant difference in initial 
growth rates (median initial growth rate for 614D clusters = 117 year​-1​, versus 169 year​-1​for 
614G clusters; Kruskal Wallis p = 0.13). This corresponds to an R​0​ of 3.1 (interquartile range, 
IQR: 2.7-3.5) for 614D clusters and 4.0 (IQR: 3.1-4.8) for 614G clusters, assuming a 6.5 day 
serial interval ​(Flaxman et al., 2020)​. The region of sample collection was not significantly 
associated with growth rates (weighted least squares, p=0.248). We did not observe a 
significant association between growth rates and the first detection date of a cluster (weighted 
least squares, p=0.62).  
 
We next examined if there was a detectable difference in growth rates by combining information 
from the virus phylogeny and the empirical frequency of sampling of the 614G variant over time. 
We conducted a model-based phylodynamic analysis using 200 sequences sampled randomly 
from the London metropolitan area (see Phylodynamic Methods). A phylogeographic model 
specified the relationship between the London sequences and a random sample of 100 
sequences from outside of London, thereby providing a mechanism to control for founder 
effects. Figure 3D shows the estimated frequency of 614G and 614D infections over time in 
London using this approach. We estimated that 614D was initially the most prevalent variant but 
that 614G overtook 614D in late March. A similar transition from 614D to 614G was observed in 
the empirical sampling frequencies, such that by the end of March samples from London are 
more than twice as likely to be the 614G variant. The phylogeographic model was fitted both 
with and without information about sampling frequency of 614G over time. Incorporating 
sampling information into the mode increases the estimated selection coefficient, from 0.10 
(without sampling information) to 0.26 (95% CI: -0.01-0.58) (Table 1). It is important to note that 
all fitted trajectories predict that the log odds of sampling 614G increase even if the selection 
coefficient is zero and that this is not necessarily evidence of positive selection for 614G.  
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Figure 3 |  ​Relative frequency of Spike 614 D and G over time (A-B), phylodynamic growth rates (C-D), 
and comparison of clinical severity metrics (E-G).  A) Frequency of sampling Spike 614G over time for 
clusters sampled during exponential growth phase. The size of points represents the number of samples 
 . CC-BY 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted September 1, 2020. .https://doi.org/10.1101/2020.07.31.20166082doi: medRxiv preprint 
collected on each day. The line and shaded region showed the MLE and confidence interval fit of the 
logistic growth model. B) As in (A) but including samples during a period after April 15 during a period of 
epidemic decline. C) Distribution of exponential growth rate for Spike 614G (brown) and 614D (grey) in 
units of 1/year. Solid areas span the 95% credible interval. Points indicate the rates estimated for specific 
clusters, and are sized by the number of sequences in that cluster. D) Log odds of sampling Spike 614G 
in London comparing empirical values (black line) and estimates based on the phylodynamic SEIR 
model (shaded regions). The green shaded region shows estimates making use of both genetic data and 
sample frequency data. E) The probability over time of fatal outcome within 28 days of diagnosis among 
UK patients with sequence data that can be matched to clinical records. Shaded regions show 95% 
confidence region of a 7-day moving average. Points with fewer than 20 observations are omitted. F) 
Moving average of age among samples included in (E). G) Viral load (RT-qPCR mean genome copies) 
estimated using SARS-CoV-2 RNA strands from 31 614D (614D) and 290 614G samples. 
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Association of Spike 614 replacement with infection severity, outcome, and age. ​We 
investigated associations between the D614G polymorphism and virulence by linking virus 
genome sequence data with clinical data on patient outcomes. We studied two clinical outcome 
datasets: Dataset 1 - 9,782 614G and 2,533 614D  associated genetic sequences collected by 
Public Health England between 3 February and 4 July, 2020 linked to patient outcome after 28 
days post-diagnosis (death or recovery), and Dataset 2 -  1,670 (​486 614D and 1,184 614G) 
genetic sequences collected by NHS Greater Glasgow & Clyde between 28th February and 
30th June 2020 linked to records of clinical severity. In univariate analyses of dataset 1, we 
found that patients with the 614G variant show reduced odds of death, but this effect 
disappeared after controlling for other known risk factors for severe COVID19 outcomes (Table 
2). Mortality closely tracks average age within our sample which varied greatly over time as 
testing priorities changed (Figure 3 E and F). We observed associations between time of 
sampling and genotype (later samples were more likely to have 614G) and later samples having 
higher odds of death and higher age. Odds of survival decrease for later samples, which may 
reflect prioritization of very severe cases for hospitalization and genetic sequencing as the 
epidemic peaked in March and April. For Dataset 2, clinical severity was recorded using an 
ordinal scale based on oxygen requirement (1. No respiratory support, 2: Supplemental oxygen, 
3: Invasive or non-invasive ventilation or high flow nasal cannulae, 4: Death). The association 
between the D614G polymorphism and severity of disease was estimated with high uncertainty, 
but the posterior was centered close to zero indicating that a biologically relevant effect is 
unlikely (mean: 0.03; 95% CI: -0.80-0.84). Increasing age and male biological sex were both 
associated with a marked increase in clinical severity (Figure 4, Table S1). We found a 
correlation in infection severity between individuals infected with related viruses (mean standard 
deviation of the phylogenetic random effect: 0.26; 95% CI: 0.19-1.09). However, it is unclear to 
what extent this correlation represents genetic differences between viruses underlying infection 
outcomes as opposed to being an artefact of related viruses being spatially co-located, and thus 
infecting individuals with similar characteristics.
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Figure 4  | Clinical severity in patients in association with the D614G polymorphism and 
age. ​Clinical severity was measured on a 4 point ordinal scale based on requirement for 
respiratory support. Upper panel - proportion of outcomes by age, lower panel - absolute 
counts.  I&V - intubation and ventilation; NIV - non-invasive ventilation; HFNC - high flow nasal 
cannulae; Oxygen - supplemental oxygen delivered by face mask or low-flow nasal cannulae. 
 
 
 
We observed an association between age and genotype, with younger patients more likely to 
carry 614G viruses. We see this association despite the progressive aging of the patient cohort 
(Figure 3F) and concomitant increase in prevalence of 614G relative to 614D. We performed a 
multivariate analysis on the metadata of 27,038 sequences from across the UK (England, 
Wales, Scotland, and Northern Ireland) for the sample collection date, the age and sex of 
patients. A significant difference was found between the distribution of patient ages for 614G 
and 614D (Figure S8, Mann Whitney U test: p < 10 ​-13​). The median age is 5 years older among 
female carriers of 614D versus 614G and 4 years older among male carriers of 614D versus 
614G. An association was also observed between sex and the presence of 614G or 614D 
(Figure S8, Chi-squared test: p < 10 ​-10​). Differences in the age distribution for each sex were 
also observed (Mann-Whitney U p<10 ​-8​ for 614D and p<10 ​-37​ for 614G). The probability of 
carrying 614G virus seems to decrease continuously with age (Figure S8). This is possibly due 
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to an increased viral load in younger patients associated with 614G variants leading to higher 
detection rates. 
 
 
Table 2: ​ Odds ratios (OR) of death within 28 days post diagnosis. Continuous variables were 
scaled (Z score) before regressing. Coefficients are in standardized units (Z-score). 95% 
confidence intervals are shown in parentheses.  
 
Predictor OR Adjusted OR Coefficient 
614 G  0.82 (0.74 - 0.90)  1.09 (0.97 - 1.23) 0.09 (-0.03 - 0.21) 
Sex=Male  2.15 (1.95 - 2.36) 0.77 (0.67 - 0.86) 
Age   1.63 (1.56 - 1.70)  
Time of 
sampling 
  -5.6( -6.68 - -4.62) 
 
 
 
 
As a proxy for viral load we studied 12,082 sequences with PCR cycle threshold (Ct) values 
from across the UK. Sequences with 14≤ Ct ≤ 40 were inspected for association with genotype 
and a very slight (<1 Ct step) but significant difference was observed with 614G associated with 
lower Ct (Figure S6, p <10 ​-6​, Mann-Whitney U test). As different test methods were used to 
obtain the Ct values across the dataset making a reliable comparison difficult, we carried out 
real-time quantitative viral load testing using a subset of 31 614D and 290 614G samples 
extracted on the same platform and analysed using the 2019-nCoV_N1 assay RT-qPCR assay.  
This again found a significant difference with 614G associated with higher viral load (Figure 3G, 
p=0.0151, Mann-Whitney U test).  
 
Other proximal residue replacements with potential relevance to Spike subunit function stability. 
Within the UK and global SARS-CoV-2 phylogenies there are  multiple  instances of the D614G 
mutation as well as  reversions back to 614D. The existence  of reversions implies that the 
614D wild-type is still relatively fit within individual hosts. Within the UK, we also observe two 
phylogenetic clusters of another variant, 614N, the independent origins of which suggest that 
this variant is also transmissible. However, the effect of 614N on Spike subunit function remains 
to be determined. 
 
We observed additional mutations at the residues immediately adjacent to Spike 614. The 
mutation 613H co-occurs with both 614G and 614D, possibly  as a result of convergent 
evolution. V615I occurs on the background of 614D, whilst V615F co-occurs with 614G (Table 
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3). These replacements are associated with one or two UK clusters, showing evidence for their 
transmission within the UK. Variant 615I is largely constrained to Wales, where it is associated 
with a large phylogenetic cluster that has not been observed since mid-April. Experimental 
studies will be required to determine whether these mutations proximal to site 614 have similar 
effects to 614G or, when co-occurring, have compensatory or epistatic effects. 
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Table 3: ​Circulating amino acid haplotypes found at residues 613-615 of the SARS-CoV-2 Spike 
protein. The ancestral haplotype is inferred to be QDV.  The table reports the number of distinct 
UK clusters that the respective genomes are found in. 
Haplotype 
Spike 
613-615 
Number of 
observed 
genomes 
Number of UK 
clusters 
Date of first and last 
sample  
 
 QGF 3 2 2020-04-27, 2020-04-30 
 HDV 5 1 2020-03-30, 2020-03-30 
 QNV 7 2 2020-04-01, 2020-04-22 
 QDI 20 2 2020-03-17, 2020-04-15 
 HGV 24 3 2020-03-29, 2020-04-22 
 QDV 13356 2321 2020-01-29, 2020-06-03 
 QGV 43239 7007 2020-02-23, 2020-06-14 
 
 
Discussion 
 
The variant D614G has been shown to enhance the infectivity of pseudotyped lentiviruses 
carrying SARS-CoV-2 spike protein ​ in vitro​ ​(Korber et al., 2020; Yurkovetskiy et al.)​. However 
differences in cell infectivity ​in vitro​ do not necessarily result in greater within-host infectivity, let 
alone increased transmissibility between hosts. The spread of a virus mutation is governed by 
demographic processes such as population growth, range expansion, founder effects and 
random genetic drift, as well as by potential positive selection if the mutation confers enhanced 
transmissibility.  We used available data to indirectly evaluate  the transmission fitness of the 
Spike 614G  by using a very large dataset of patient samples and a range of inference 
approaches. Some methods suggested evidence for increased population growth rates of the 
614G variant whilst others did not. Given the many factors that contribute to transmission 
dynamics, it is unsurprising the population-level values we have estimated are much less than 
the proportional increase in cell infectivity measured ​in vitro​.  
 
Estimating the epidemiological fitness of individual genetic variants during an emerging 
pandemic presents multiple challenges. The recent origin of SARS-CoV-2 combined with a 
relatively low rate of evolution means global viral genetic diversity is low and many methods for 
identifying positive selection will have low sensitivity. Evidence for positive selection at Spike 
position 614 and other sites has been suggested by statistical models based on the rate ratio of 
nonsynonymous to synonymous substitutions ​(Pond, 2020)​. However the detection of positive 
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selection by such methods does not necessarily imply the mutation enhances transmissibility, 
and effects of individual mutations on transmissibility will generally be low ​(MacLean et al., 
2020)​.  
 
 Convergent molecular evolution (resulting in homoplasies) can present an alternative sources 
of information about potentially beneficial virus mutations (ADD REF) However, such 
approaches lack sensitivity for the D614G as almost all circulating 614G genomes derive from a 
single ancestor ​(van Dorp et al., 2020)​. Our discovery of co-occurring mutations in neighbouring 
sites ( 615 and 613) and  the D614N variant is suggestive of a more complex selective 
landscape in this region of the Spike protein than was first indicated. We also note that our 
analysis is limited by necessity to the comparison of co-circulating clusters that, in some cases, 
are characterised by mutations at sites other than 614, hence it is impossible to disentangle the 
selective effects of each individual mutation. One amino acid replacement is notable: RdRp 
P323L, occurred almost concurrently with D614G, and is in almost perfect linkage equilibrium 
with 614G ​(Pond, 2020)​.  
 
We have drawn on two sources of information regarding the growth of the 614G variant, (i) the 
relative frequency of the 614G and 614D variants through time, and (ii) inferred differences in 
the genetic diversity and growth rate of 614G and 614D phylogenetic clusters in the UK 
(phylodynamics). Whilst the changing frequency of one variant in an exponentially-growing 
population can in theory indicate a difference in fitness, the rate at which 614G clusters were 
imported and discovered in the UK also changed through time, making direct comparisons of 
variant frequencies challenging. We attempted to  control for this effect using phylogenetic 
analysis and by counting only samples derived from co-circulating clusters representing distinct 
introductions of SARS-CoV-2 into the UK. Separately, phylodynamic methods allow us to infer 
the growth and decline in effective population size of individual phylogenetic clusters, and we 
used this approach to compare  the mean growth rates of  614G and 614D clusters. These 
phylodynamic estimates have high statistical uncertainty  and do not consistently detect a 
significant difference in growth rate between the two variants . We observed, however, that 
614G clusters tend to grow to a larger size than 614D clusters after controlling for time of 
introduction into the UK. This is consistent with a transmission advantage of 614G variants, but 
could also be the result of unknown confounders which increase the probability that 614G 
lineages will be sampled. Our data will be naturally biased towards samples that are easy to 
sequence, and we have observed a very slight but significant decrease in the  RT-PCR Ct 
values of the 614G variant. 
 
Several limitations of the data and analysis should be considered when interpreting our finding 
that the sampling frequency of variant 614G increased . We have applied classic population 
genetic models premised on contrasting the exponential growth rates of the 614G and 614D 
populations while controlling for founder effects, but in reality the SARS-CoV-2 epidemic is noisy 
and structured in ways not accounted for by this model. The frequency of 614G and 614D 
variants can change rapidly due to stochastic fluctuations, especially early in the epidemic. The 
sampling process is also inhomogeneous through time and sometimes  reactive to short-term 
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public health situations (e.g. nosocomial outbreaks)  rather than being fully randomised and 
systematic. Most of the SARS-CoV-2 genome sequencing performed by centres in the UK is 
focused on symptomatic cases, often using diagnostic residual samples. As testing priorities 
change, and as cases in different segments of the population fluctuate, signals may emerge that 
are due to operational changes rather than shifts in virus biology. 
 
Phylodynamic estimates of reproduction numbers are sensitive to the context of early spread of 
epidemic clusters which may have involved superspreading events ​(Endo et al., 2020)​. These 
events are highly variable and phylodynamic methods are inherently imprecise with poorly 
resolved phylogenies. The Spike 614 polymorphism explains little variance in the rate of spread 
of individual clusters, but incorporating additional information about the frequency of sampling 
614G and 614D variants improved precision of phylodynamic estimates.  Estimates of the 
reproduction number based on large clusters are not representative of the epidemic as a whole 
and may be larger on average. 
 
SARS-CoV-2 case and infection fatality rates seem to vary widely among countries and through 
time. It is unclear to what degree this variation reflects estimation uncertainty, host population 
factors (such as the age structure of the population ​(Onder et al., 2020)​) or virus genetic factors 
Here, we do not detect a difference in virulence between the two Spike 614 variants. By 
estimating mortality rates as opposed to rates of hospitalization or ICU care, our results 
complement those in ​(Korber et al., 2020)​ and are based on a substantially greater sample size. 
In addition, we did not find any association with clinical severity indicated by  the requirement for 
oxygenation or respiratory support in a subset of 1670 patients. A significant association of 
614G carriage with age may indicate minor differences in clinical outcome or frequency of 
symptomatic infection, which bears further study. The data is heavily skewed towards 
hospitalized cases, and therefore more severe disease , and so it is not possible to evaluate 
small differences in virulence that may be present in milder or asymptomatic infections. This is 
especially problematic for evaluating effects that may be confounded by age, as the proportion 
of infections that do not lead to symptoms is higher in younger individuals​(Davies et al., 2020)​.  
 
Our analysis emphasises that while laboratory experiments can identify changes in virus 
biology, their extrapolation to identify population level effects on transmission requires caution. 
In the case of D614G, a large increase in cellular infectivity results in a weak population-level 
signal that nonetheless produces a discernible effect on transmissibility.  While we believe an 
effect on SARS-CoV-2 transmissibility caused by D614G is likely to be present, it is important to 
note that the estimation of the absolute size of this effect is uncertain and much harder to 
predict. Although the signal is difficult to detect, the unprecedented size and completeness of 
the UK dataset and associated metadata enables many potential biases within the data to be 
controlled for. This work is therefore demonstrative of the value of large-scale coordinated 
sequencing activities to understand a pandemic in real time.  
 
This study shows that transmissibility of SARS-CoV-2 can change as the pandemic unfolds. 
Whether the current explosive epidemics across the world are to any degree being driven by 
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D614G, or whether it is simply the beneficiary of being in the right place at the right time, it is 
now the dominant variant. Changes in the transmissibility of a circulating virus could have a 
major effect on pandemic planning and the effectiveness of pandemic response, and so it is 
critical that the parameters for models  used for planning are based on the currently circulating 
virus. Work on vaccines, therapeutics and other interventions must allow for this but also keep 
in mind that reversions, and other mutations at the same or adjacent residues, will undoubtedly 
emerge in the future. 
 
 
Methods 
 
Sample collection and sequencing.​ We utilized data from the Coronavirus Disease 2019 
(COVID-19) Genomics UK Consortium (CoG-UK)​(The COVID-19 Genomics UK (COG-UK) 
consortium, 2020)​, a partnership of more than 18 academic, medical and public health research 
centres contributing sequencing and analysis capabilities. Sequence data was generated from a 
variety of protocols and platforms and were uploaded to a centralized environment for storage 
and analysis (MRC-CLIMB) (​https://www.climb.ac.uk/​)​(Connor et al., 2016)​. Data are uploaded 
with a standard set of clinical and demographic metadata and information about sequencing 
protocols and sample collection methods. Data undergo quality control and assembly and 
lineage assignment ​(Rambaut et al.)​. Data which complete quality control and assembly steps 
are released on a weekly basis. Sequence data are periodically shared through two open 
access databases, the European Bioinformatics Institute ​(Rodriguez-Tomé and Stoehr, 1996) 
and the Global Initiative on Sharing All Influenza Data ​(Shu and McCauley, 2017)​. We utilized 
26,986 whole genome sequences contained in the June 19 release 
(​https://www.cogconsortium.uk/data/​)  and for which the Spike 614 genotype could be 
determined and sample collection date was known.  
 
Phylogenetics and calculation of maximum parsimony clusters. ​Maximum likelihood (ML) 
phylogenetic trees were estimated separately using IQTree ​v1.6.12​ for major global lineages 
(Minh et al., 2020; Rambaut et al.)​. Phylogenies were rooted on a sample from the ancestral 
lineage.  UK clusters were identified using parsimony-based ancestral state reconstruction 
(Fitch, 1977)​ with internal nodes classified as UK or non-UK. Most UK clusters are descended 
from polytomies with descendents in multiple countries, and reconstruction of ancestral states at 
such nodes is ambiguous. In such cases the polytomy node was assigned the same state as it’s 
ancestor.  We consider two extremes of the maximum parsimony method for reconstructing 
ancestral states at bifurcating nodes: Accelerated transition (AT) which favours transitions to the 
UK as close to the root of the tree as possible, and delayed transition (DT) which favours 
transition to the UK as far from the root as possible. Unless otherwise stated, results are based 
on DT clusters which are more likely to represent transmission within the UK.  
 
Statistical analyses.​ Size of clusters was evaluated using log-linear multivariate regression. 
Effect of genotype on phylodynamic growth rates was estimated using multivariate weighted 
regression. Regression weights are inversely proportional to precision of estimated growth 
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rates. Univariate comparisons used the Kruskal Wallis test. Kernel density estimation of sample 
time distributions used gaussian kernels and a bandwidth of 2 days. Statistical models were 
implemented in R 3.6.3.  
 
Logistic growth model. ​ According to this model the number of infected with the Spike 614D 
variant grows exponentially at a rate  and the number with the Spike 614G variant grows 
exponential at rate . If  is the number infected initially with variant , the proportion 
of the population with Spike 614G at time  is  
 
 
This model can be fitted to a sequence of sample times  with Spike 614 genotypes 
 by maximum likelihood. The objective function is  
  
Formally, fitting this model is equivalent to logistic regression of genotype on time where the 
coefficient corresponds to the compound parameter .  Deriving the selection 
coefficient therefore requires additional information about the growth rate . For the model fitted 
to data during the exponential growth phase, we considered a range of plausible values for this 
rate corresponding to a reproduction number in the range 2.0-3.5 and a serial interval of 6.5 
days​(Flaxman et al., 2020)​. For the model fitted to data during the decline phase, we considered 
a rate corresponding to a generation time between 3 and 8 days. The final confidence interval is 
based on these ranges as well as the confidence interval of  computed using profile likelihood. 
 
Phylodynamic analysis of cluster growth rates with parametric coalescent model. 
We used a two-epoch coalescent model to estimate a period of exponential growth followed by 
an independently estimated period of exponential decline. Note that although we refer to growth 
and decline, the growth rates for both epochs can take either positive or negative values. The 
transition time from growth to decline was estimated independently for each cluster using a 
normal prior with a mean of the 23rd March 2020 (2020.2254), the date of ‘lockdown’ in the UK, 
and a standard deviation of two weeks. The data consisted of delayed transition clusters of 
more than 40 sequences as of the 19th June 2020.  
 
A normal hyperprior is specified for cluster growth/decline rates for each genotype and the 
mean and precision of the hyperprior are estimated. The posterior mean growth/decline rates for 
each genotype are estimated along with the growth/decline rate for each cluster individually. 
Posterior growth rates within each genotype are therefore correlated. The prior for the mean 
growth rate is Normal(0,100/year) and the prior of the precision parameter is Gamma(1,0.001). 
We compute the selection coefficient from growth rates with the formula  where  is 
the mean growth rate for each group of clusters.  
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The model was implemented in BEAST v1.10.5 ​(Suchard et al., 2018)​. Four independent chains 
of 100m states were run for each variant, with 10% removed from each chain to account for 
burn-in. Convergence was assessed using Tracer​(Rambaut et al., 2018)​ prior to further 
analysis. The HKY model was used to model nucleotide evolution ​(Hasegawa et al., 1985)​, and, 
following Duchene et al.​(Duchene et al., 2020)​, the evolutionary clock rate was fixed at 0.001 
substitutions per site per year. Other priors used are described in table S2. 
 
Phylodynamic analysis of cluster growth rates with non-parametric coalescent model. ​Rooted 
and dated phylogenies were estimated by randomly resolving polytomies in the ML trees 
described above using ​ape 5.3​(Paradis et al., 2004)​ and ​treedater​ 0.5.1 ​(Volz and Frost, 2017)​. 
The mean clock rate of evolution was constrained to (0.00075,0.0015). Branch lengths were 
smoothed by enforcing a minimum number of substitutions per site on each branch and by 
sampling from the distribution estimated by ​treedater​. This was carried out 20 times for each UK 
lineage. Growth rates were estimated using ​skygrowth ​0.3.1 ​(Volz and Didelot, 2018)​ using 
Markov chain Monte Carlo (MCMC) and 1 million iterations for each time tree and using an 
Exponential(10 ​-4​) prior for the smoothing parameter. The final results were produced by 
averaging across 20 time trees estimated for each cluster. Code to reproduce this analysis is 
available at ​https://git.io/JJkIM​ and an interactive dashboard showing growth and decline of UK 
lineages can be viewed at ​https://shiny.dide.imperial.ac.uk/s614LineagesUK/​.  
 
Model-based phylodynamic analysis.​ We applied a susceptible-exposed-infectious-recovered 
(SEIR) model ​(Diekmann and Heesterbeek, 2000)​ for the SARS-CoV-2 epidemic in London 
linked to an international reservoir. The SEIR model assumed a 6.5 day serial interval. The 
estimated parameters included the initial number infected, the susceptible population size, and 
the reproduction number. The model included bidirectional migration to the region outside of 
London (both within the UK and internationally) at a constant rate per lineage. Evolution outside 
of London was modelled using an exponential growth coalescent. Additional estimated 
parameters include the migration rate, and the size and rate parameters for the exponential 
growth coalescent. This model was implemented in the BEAST2 PhyDyn package ​(Bouckaert et 
al.; Volz and Siveroni, 2018)​ and is available here: ​https://git.io/JJUZv​. The phylogenetic tree 
was co-estimated with epidemiological parameters. In order to make results comparable 
between 614D and 614G lineages, the molecular clock rate of evolution was fixed at a value 
estimated using all data in ​treedater​ 0.5.1. Nucleotide evolution was modeled as a strict clock 
HKY process ​(Hasegawa et al., 1985)​.  To fit the model we ran 20 MCMC chains for 20 million 
iterations, each using 4 coupled MCMC chains ​(Müller and Bouckaert, 2020)​. Bespoke 
algorithms were used to exclude chains which failed to sample the target posterior. We used 
identical uninformative Lognormal( mean log=0, sd log = 1) priors for the reproduction number in 
614G and 614D lineages.  
 
The model was fitted to 614G and 614D sequence data separately before being combined for 
joint inference with the sample frequency data. This is carried out using a 
sampling-importance-resampling strategy​(Smith and Gelfand, 1992)​. We sampled parameters 
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from the posterior estimated from genetic data uniformly and computed importance weights 
using a sequential Bernoulli likelihood based on the estimated frequency of 614G and 614D 
over time. Parameters resampled 1 million times with these weights yield our final estimate of 
the posterior.  
 
The selection coefficient given a ratio of reproduction numbers is computed as follows: 
 
 
Analysis of severity of patient outcomes 
We aggregated data from 1670 patients presenting with COVID-19 from NHS records and 
combined it with the genome sequence of the virus infecting them. We used a phylogenetic 
generalised additive model to investigate the viral D614G polymorphism and association with 
severity of the infection. 
To control for the effect of other mutations in the genome, we generated a time tree of the virus 
genomes from Scotland using an HKY + Γ nucleotide model excluding the nucleotide position 
underlying the D614G mutation. We estimated the tree using IQ-TREE 2 v. 2.0.6 ​(Minh et al., 
2020)​. We masked the nucleotide causing the D614G mutation, as well as all mutations 
recommended by De Maio et al. as of 22/7/2020 
(https://virological.org/t/issues-with-sars-cov-2-sequencing-data/473/13). We included the first 
sequenced genome of SARS-CoV-2 from China ​(Wu et al., 2020)​ as an outgroup to root the 
tree. 
We coded the severity of infection as four levels: 1) No respiratory support, 2) Supplemental 
oxygen, 3) Invasive or non-invasive ventilation or high flow nasal cannulae, 4) Death. We 
modified the WHO ordinal scale to these 4 points to avoid using hospitalisation as a criterion of 
severity because 1) many patients in nursing homes had severe infection but were not admitted 
to hospital, and 2) early in the outbreak, all cases were hospitalised irrespective of the severity 
of their infection. Our model included the presence of the D614G mutation and the biological 
sex of the patient as categorical predictors, as well as age and the time since the first case in 
the dataset as non-linear predictors. We include the time in days since the first case in the 
dataset to control for changes in treatment practice across the course of the epidemic. We 
mean-centred age and time in days and modelled their nonlinearities using penalised regression 
splines with a maximum of 30 knots. If a case was associated with a cluster of cases, for 
instance in a hospital ward or nursing home, this was included as a random effect with each 
cluster getting its own level. We gave any cases not associated with clusters their own unique 
level. Finally, to account for correlations driven by genome similarity that are not due to the 
D614G mutation, we generated a variance-covariance matrix (scaled to a correlation matrix) 
from the phylogeny described above (after dropping all tips corresponding to genomes not in the 
dataset) using the ​ape​ package v. 5.3 ​(Paradis and Schliep, 2019)​ and included that as a 
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random effect in the model. We modelled the ordinal nature of the data using a cumulative 
model that assumes multiple thresholds corresponding to each severity level on the logit scale. 
The model was fit in a Bayesian framework using Hamiltonian Monte Carlo in the R package 
brms​ v. 2.13.5 ​(Bürkner, 2018)​, a front-end for ​rstan​ v. 2.21.2 ​(Stan Development Team, 2020)​. 
The model had no divergent transitions, Gelman-Rubin values less than 1.01 and both bulk and 
effective sample sizes of greater than 950 for all parameters. Shortest probability intervals for 
reporting were generated by the R package ​SPIn​ v. 1.1 (Liu et al. 2015). 
Priors: We used weakly informative priors to constrain the model to sensible values on the link 
scale, but not rule out any reasonable values. All thresholds for the dividing lines between 
severity levels were given t-distribution (mean = 0, scale = 2.5, df = 3) priors and all fixed effects 
were given Gaussian (mean = 0, standard deviation = 2.5) priors. The standard deviations for 
the random effects and penalised splines were given Exponential (lambda = 0.4) priors, 
corresponding to a prior mean of the standard deviation of 2.5, the same as the fixed effects. 
Clinical sample quantitative PCR 
All samples were tested in duplicate using the 2019-nCoV_N1 assay RT-qPCR assay 
(https://www.fda.gov/media/134922/download); primers and probe were obtained ready-mixed 
from IDT (Leuven, Belgium). PCRs were performed in a final volume of 20 µl and included NEB 
Luna Universal Probe One-Step Reaction Mix and Enzyme Mix (New England Biolabs, Herts, 
UK), primers and probe at 500 nM and 127.5 nM, respectively, and 5 µl of RNA sample. No 
template controls were included after every seventh sample. Six ten-fold dilutions of 
SARS-CoV-2 RNA standards were tested in duplicate in each assay; standards were calibrated 
using a plasmid containing the N sequence that had been quantified using droplet digital PCR. 
Thermal cycling was performed on an Applied Biosystems™ 7500 Fast PCR instrument running 
SDS software v2.3 (ThermoFisher Scientific) using the following conditions: 55oC for 10 minutes 
and 95oC for 1 minute followed by 45 cycles of 95oC for 10 s and 58oC for 1 minute. Assays 
were repeated if the reaction efficiency was <90% or the R2 value of the standard curve was 
≤0.998. Where possible, testing of samples was repeated if the %CV of the duplicates was 
<10%. Three samples were not tested in duplicate because of insufficient RNA. Two samples 
had Cq values that were below the top SARS-CoV-2 RNA standard in the assay. Duplicate 
PCRs from four samples had %CVs >10 (range 10.19 to 17.06). 
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Supporting figures and tables 
 
 
Figure S1 ​| Expanded phylogenetic tree showing the early stages of emergence of D614G into 
Europe from China. Acknowledgments and details for highlighted genome sequences are given 
in Table S3.  
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Figure S2 ​: Frequency of sampling Spike 614G over time (A) and numbers of Spike 614G and 
Spike 614D samples over time(B). The size of points represents the number of samples 
collected on each day. The line and shaded region showed the MLE and confidence interval 
fit of the logistic growth model.  
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Figure S3 ​: Frequency of sampling Spike 614G after April 15 and numbers of Spike 614G and 
Spike 614D samples over time using 37 DT clusters detected before March 31, 2020. The 
size of points represents the number of samples collected on each day. The line and shaded 
region showed the MLE and confidence interval fit of the logistic growth model.  
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Figure S4: ​The estimated TMRCA for each of 50 UK clusters (shaded density) and time of 
each sequence sampled (points). Brown and grey respectively indicate Spike 614G and 614D 
clusters.  
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Figure S5: ​ Distribution of exponential growth rates (left) and rates of decline(right) for Spike 
614G (brown) and 614D (grey) in units of 1/year. Solid areas span the 95% credible interval. 
Points indicate the rates estimated for specific clusters, and are sized by the number of 
sequences in that cluster.  
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Figure S6: ​Estimated growth rates (A and C) and effective population size (B and D) for the 
two largest clusters with genotypes Spike 614D/G. The growth rate at the beginning of the 
time axis (Feb 1, 2020) is shown in panel E and provides a data point for the statistical 
comparisons between clusters. The size of points corresponds to the number of samples in 
each cluster.  
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Figure S7. ​Frequency histograms of PCR cycle threshold (Ct) for D/G variants overlaid 
with kernel density estimates. Samples where the amino acid at position 614 was not 
recorded and samples with a Ct value of less than 14 or greater than 40 were excluded. 
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Figure S8 ​:  Probability of observing Spike 614G virus in patients grouped by age and sex. 
Collected pairwise plots are based on a UK-wide (England, Wales, Scotland, and Northern 
Ireland) multivariate dataset for the sample collection date, and the age and sex of the patient. 
Kernel Density Estimation (KDE) and count plots are on the diagonal. 
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Effect 
Posterior 
mean 
Lower bound of 95% 
shortest probability 
interval 
Upper bound of 95% 
shortest probability 
interval 
Presence of 614G 0.03 -0.80 0.84 
Female biological sex -0.72 -0.95 -0.50 
Threshold 1 0.07 -0.36 0.49 
Threshold 2 0.92 0.50 1.34 
Threshold 3 1.28 0.85 1.71 
Cluster random effect 
standard deviation 0.26 0.00 0.58 
Phylogenetic random effect 
standard deviation 0.62 0.19 1.09 
Age penalised spline 
standard deviation 1.34 0.15 2.94 
Days since first case in the 
dataset penalised spline 
standard deviation 5.98 2.39 10.27 
 
Table S1 ​Posterior values for regression coefficients and standard deviations for the severity 
analysis of Dataset 2  
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Parameter Prior distribution Shape parameters 
Kappa (HKY) Lognormal Mu = 1.0 Sigma=1.25 
Population size (for each 
lineage) 
Lognormal Mean = 1.0 Stdev = 1.5 
Hyperprior for mean growth 
and decline rate 
Normal Mean = 0 Stdev = 100 
Hyperprior for precision of 
growth and decline rate 
Gamma Shape = 1 Scale = 0.001 
Transition time Normal Mean = 2020.2254 in node 
height of the individual cluster 
tree Stdev = 0.034 
 
Table S2 ​Prior distributions used in the BEAST analysis (see Main text). 
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Name  GISAID ID  Date  Laboratories  Authors 
Sichuan/SC-PHCC1-022  EPI_ISL_451345  2020-01-24  West China Hospital of 
Sichuan University / 
State Key Laboratory of 
Biotherapy of Sichuan 
University 
Baowen Du, Minjin Wang, 
Chao Tang, Chuan Chen, 
Yongzhao Zhou, Mingxia 
Yu, Hancheng Wei, Weimin 
Li, Jing-wen Lin, Jia Geng, 
Binwu Ying, Lu Chen 
Shanghai/SH0014  EPI_ISL_416327  2020-01-28  Shanghai Public Health 
Clinical Center, 
Shanghai Medical 
College, Fudan 
University / National 
Research Center for 
Translational Medicine 
(Shanghai), Ruijin 
Hospital affiliated to 
Shanghai Jiao Tong 
University School of 
Medicine & Shanghai 
Public Health Clinical 
Center 
Shengyue Wang, Xiaonan 
Zhang, Gang Lu, Yun Tan, 
Yun Ling, Hongzhou Lu, 
Saijuan Chen 
Shanghai/SH0086  EPI_ISL_416386  2020-01-31  Shanghai Public Health 
Clinical Center, 
Shanghai Medical 
College, Fudan 
University / National 
Research Center for 
Translational Medicine 
(Shanghai), Ruijin 
Hospital affiliated to 
Shanghai Jiao Tong 
University School of 
Medicine & Shanghai 
Public Health Clinical 
Center  
Shengyue Wang, Xiaonan 
Zhang, Gang Lu, Yun Tan, 
Yun Ling, Hongzhou Lu, 
Saijuan Chen 
Shanghai/SH0025  EPI_ISL_416334  2020-02-06  Shanghai Public Health 
Clinical Center, 
Shanghai Medical 
College, Fudan 
University / National 
Research Center for 
Translational Medicine 
(Shanghai), Ruijin 
Hospital affiliated to 
Shanghai Jiao Tong 
University School of 
Medicine & Shanghai 
Public Health Clinical 
Center  
Shengyue Wang, Xiaonan 
Zhang, Gang Lu, Yun Tan, 
Yun Ling, Hongzhou Lu, 
Saijuan Chen 
Guangzhou/GZMU0019  EPI_ISL_429080  2020-02-05  The First Affiliated 
Hospital of Guangzhou 
Medical University 
Yanqun Wang, Daxi Wang, 
Lu Zhang, Wanying Sun, 
Zhaoyong Zhang et al. 
Guangzhou/GZMU0037  EPI_ISL_429089  2020-02-08  The First Affiliated 
Hospital of Guangzhou 
Medical University 
Yanqun Wang, Daxi Wang, 
Lu Zhang, Wanying Sun, 
Zhaoyong Zhang et al. 
Guangzhou/GZMU0020  EPI_ISL_429081  2020-02-05  The First Affiliated 
Hospital of Guangzhou 
Medical University 
Yanqun Wang, Daxi Wang, 
Lu Zhang, Wanying Sun, 
Zhaoyong Zhang et al. 
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Germany/BavPat1  EPI_ISL_406862  2020-01-28  Charité 
Universitätsmedizin 
Berlin, Institute of 
Virology; Institut für 
Mikrobiologie der 
Bundeswehr, Munich 
Victor M Corman, Julia 
Schneider, Talitha Veith, 
Barbara Mühlemann, 
Markus Antwerpen, 
Christian Drosten, Roman 
Wölfel 
Table S3 ​Early D614G viruses in lineage B. 
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